FIRDAPSE® (amifampridine) HCP

This content is intended for US healthcare professionals (HCPs). If you are a patient, please visit firdapse.com.


Our FIRDAPSE channel is designed for US HCPs, with content that focuses on elevating patient care through clinical treatment information, perspectives of peers, and testimonials from real patients. Enjoy these videos and subscribe to our channel for the latest updates. Please see full Prescribing Information and Patient Information in the links below.

FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.

See full Important Safety Information and Prescribing Information at the links below.

FIRDAPSE® is a registered trademark of SERB.
© 2026 Catalyst Pharmaceuticals, Inc. All Rights Reserved.

FIR-0439-2 January 2026